ODTX
Odyssey Therapeutics, Inc.
Set alert
19.54 USD -0.29 -1.46%
19.12 Day range 20.20
15.56 52-week range 28.76
- YTD
- +19.00%
- 1 year
- +19.00%
- Open
- 19.77
- Prev close
- 19.83
- Mkt cap
- 939.06M
- Vol
- 166.40K
- Avg vol
- 262.12K
- EPS
- -7.55
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 19.12
- High
- 20.20
- Forward P/E
- -4.78
- Beta
- 0.00
- Short ratio
- 11.58
- Inst. own
- 83.08%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 22.53
- 200-d avg
- 19.92
- 1y target
- 35.75
Financial health
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 4
Valuation
P/E -3.0×
FY 2025 5y median -3.0× FY 2025
P/S 152×
FY 2025 5y median 152× FY 2025
P/B -0.9×
FY 2025 5y median -0.9× FY 2025
P/FCF -3.5×
FY 2025 5y median -3.5× FY 2025
EV/EBITDA -3.0×
FY 2025 5y median -3.0× FY 2025
EV/Sales 147×
FY 2025 5y median 147× FY 2025
FCF Yield -28.9%
FY 2025 5y median -28.9% FY 2025
Profitability
Gross Margin 100.0%
FY 2025 5y median 100.0% FY 2025
Operating Margin -5415.2%
FY 2025 5y median -5415.2% FY 2025
Net Margin -4994.9%
FY 2025 5y median -4994.9% FY 2025
ROE 30.4%
FY 2025 5y median 30.4% FY 2025
ROIC -64.4%
FY 2025 5y median -64.4% FY 2025
ROA -55.1%
FY 2025 5y median -55.1% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2025 FY 2025
Operating Income 0.0%
FY 2025 FY 2025
EPS (diluted) 0.0%
FY 2025 FY 2025
Free Cash Flow 0.0%
FY 2025 FY 2025
Financial Health
Current Ratio 7.2×
FY 2025 5y median 7.2× FY 2025
Quick Ratio 7.2×
FY 2025 5y median 7.2× FY 2025
Debt / Equity -0.1×
FY 2025 5y median -0.1× FY 2025
Net Debt / EBITDA 0.1×
FY 2025 5y median 0.1× FY 2025
Interest Coverage -9480×
FY 2025 5y median -9480× FY 2025
Dividends
Dividend Yield 0.0%
FY 2025 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2025 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31